A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence
NCT ID: NCT00303030
Last Updated: 2011-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
126 participants
INTERVENTIONAL
2006-05-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Background: Faecal incontinence affects mainly women who have suffered sphincter disruption from vaginal delivery, but individuals of all ages can be affected. The treatment of this debility is not uniform between institutions or internationally. Often is surgical reconstruction of the anal sphincter performed, or other invasive, costly treatment options.
The study: We intend to conduct a randomized, controlled, clinical trial where we compare the effect of two less invasive, less costly treatment options as a first alternative: biofeedback and anal injections. Our hypothesis is that anal injections will give a better and more lasting effect than biofeedback. The primary endpoint will be change in faecal incontinence assessed by the St. Marks incontinence score. Secondary endpoints will include change in quality of life and several physiological parameters. We intend to include 62 patients in both groups, 124 all together, from 2 centres in Norway. The observation time is 2 years. We plan to include the first patient April 2006, and conclude the study by December 2010. This study can contribute to a more appropriate treatment-algorithm for these patients.
Study group:
* Barthold Vonen MD PhD, Department of gastroenterological surgery, University Hospital of North Norway
* Rolv-Ole Lindsetmo MD PhD, Department of gastroenterological surgery, University Hospital of North Norway
* Arvid Stordahl MD PhD., Department of Surgery, Østfold Hospital Fredrikstad
* Ylva Sahlin MD PhD, Department of Surgery, Innlandet Hospital Hamar
* Trond Dehli, MD, Department of gastroenterological surgery, University Hospital of North Norway
* Kjersti Mevik, Stud. Med, University of Tromso
Project manager: Trond Dehli
Funding, approvals, publication: This study is funded from Northern Norway Regional Health Authority and The Institution of Norwegian Health- and rehabilitation-organizations. It has been approved by the Regional Committee for Medical Research Ethics and Norwegian Social Science Data Services. The results will be published in an international peer-reviewed journal after the Vancouver-convention's guidelines. The results will also be presented at national and international conferences.
Contact:
Trond Dehli, Department of gastroenterological surgery, University hospital North Norway, Breivika, 9038 Tromsø [email protected] tlf: +47 776 26 000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1. Anal injection
1. Anal injection
Submucosal injection just above the linea dentata in the anal canal of 4 x 1 ml of dextranomere.
2. Biofeedback
2. Biofeedback
Training under the guidance of a physiotherapist with the help of a biofeedback device with an anal probe.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1. Anal injection
Submucosal injection just above the linea dentata in the anal canal of 4 x 1 ml of dextranomere.
2. Biofeedback
Training under the guidance of a physiotherapist with the help of a biofeedback device with an anal probe.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* St. Marks score of 4 or more
* No known local or general neurological disease
* 18 years or older
* No constipation
Exclusion Criteria
* Diabetes mellitus with late complications (neurological og cardiovascular)
* Ulcus simplex/rectal ulcus
* Anal/rectal prolapse
* ileo-anal anastomosis
* Cancer recti or cancer ani last 2 years
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Foundation for Health and Rehabilitation
OTHER
University Hospital of North Norway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barthold Vonen, M.D., Ph.D.
Role: STUDY_DIRECTOR
University of Tromsø, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Innlandssykehuset Hamar
Hamar, , Norway
Anorektallaboratoriet, Østfoldsykehuset Sarpsborg
Sarpsborg, , Norway
Avdeling for gastroenterologisk kirurgi, University hospital of North Norway
Tromsø, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Biofeedback or injections
Identifier Type: -
Identifier Source: org_study_id